Cause of death, by non-communicable diseases, ages 0-4, female in South Asia (IDA & IBRD)
South Asia (IDA & IBRD): Cause of death, by non-communicable diseases, ages 0-4, female was 15.0% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, female in South Asia (IDA & IBRD), 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, female in South Asia (IDA & IBRD) stood at 15.0%. That is the highest value across all 6 years on record.
The figure is up 0.5% on the previous year and up 74.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in South Asia (IDA & IBRD) peaked at 15.0% in 2021 and was at its lowest, 6.7%, in 2000.
That places South Asia (IDA & IBRD) 28th out of 47 groups with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4, female in South Asia (IDA & IBRD), year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 6.7% | — |
| 2010 | 8.6% | +28.8% |
| 2015 | 11.5% | +34.0% |
| 2019 | 14.2% | +22.9% |
| 2020 | 15.0% | +5.5% |
| 2021 | 15.0% | +0.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.7% | 6.7% | 6.7% | 1 |
| 2010s | 11.4% | 8.6% | 14.2% | 3 |
| 2020s | 15.0% | 15.0% | 15.0% | 2 |
Countries ranked near South Asia (IDA & IBRD)
More health data for South Asia (IDA & IBRD)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 2.39 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0338 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 2.72 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0391 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 0.9874 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0372 units per person (2025)
- Population ages 30-34, female, annual growth rate 1.11 % change on previous year (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in South Asia (IDA & IBRD)?
- Cause of death, by non-communicable diseases, ages 0-4, female in South Asia (IDA & IBRD) was 15.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in South Asia (IDA & IBRD)?
- The highest recorded value was 15.0% in 2021.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in South Asia (IDA & IBRD)?
- The lowest recorded value was 6.7% in 2000.
- How does South Asia (IDA & IBRD) rank for cause of death, by non-communicable diseases, ages 0-4, female?
- South Asia (IDA & IBRD) ranks 28th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in South Asia (IDA & IBRD)?
- Over the last ten years it is up 74.6%. The long-run trend across the full record is rising.
- Where does this South Asia (IDA & IBRD) data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.